美通社

2024-12-16 18:13

Fangzhou Inc. Garners Prestigious "Most Valued Pharmaceutical & Healthcare Enterprise" Award

SHENZHEN, China, Dec. 16, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was honored with a "Most Valued Pharmaceutical & Healthcare Enterprise" award at the grand "9th Zhitong Finance Capital Market Summit and Listed Company Gala" held in Shenzhen, China.

Mr. Xie Fangmin, Chairman and CEO of Fangzhou, stated, "We are honored to receive this award. This recognition underscores our dedication to advancing technological innovation and supporting the high-quality development of the Internet healthcare industry."

A "Most Valued Pharmaceutical & Healthcare Enterprise" award is bestowed upon exceptional pharmaceutical and healthcare companies listed in Hong Kong and the United States, recognizing their robust corporate governance, industry leadership, and strong business performance.

As a pioneer in the Internet healthcare sector, Fangzhou has been listed on the main board of the Hong Kong Stock Exchange since July 2024 and was included in the Hang Seng Hong Kong-Listed Biotech Index ("HSHKBIO") as of December 9, 2024.

Since its inception, Fangzhou has focused on leveraging advanced technologies, including AI technology and big data, to enhance its chronic disease management platform and provide patients and doctors a better user experience. Receiving this award highlights the Company's strong industry recognition, and its ongoing commitment to driving innovation in the online healthcare sector.

About Fangzhou Inc.
Fangzhou Inc. (06086.HK) is China's leading online chronic disease management platform. With 45.6 million registered users and 217,000 registered doctors on its platform (as of June 30, 2024), the Company provides tailored medical care and precision medicine for a growing population of chronic disease patients. For more details, visit https://investors.jianke.com.

About the Zhitong Finance Capital Market Summit and Listed Company Gala
The "9th Zhitong Finance Capital Market Summit and Listed Company Gala " was jointly hosted by Zhitong Finance, a leading Hong Kong and U.S. stock information platform, and New Wisdom Fund Network, a one-stop service platform for Chinese overseas private equity funds. The conference gathered representatives from top domestic and international financial institutions and chief economists, along with over 300 senior executives from Hong Kong and U.S. stock listed companies, 100+ US equity funds and more than 1,000 professional investors, collectively exploring investment opportunities in Chinese assets in 2025. Over its nine consecutive years of successful hosting, the summit has garnered significant acclaim and influence in the nation's capital markets.

Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com 

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements

source: Fangzhou Inc.

《說說心理話》心理急救II:幾個徵兆辨認身邊人需要心理支援!點樣對情緒進行急救、自我照顧?專家分享穩定情緒小練習► 即睇

人氣文章
財經新聞
評論
專題
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【etnet 30周年】多重慶祝活動一浪接一浪,好禮連環賞!

【etnet30周年連環賞】睇住賞Maxcare美天復康寶(升級版) (價值HK$1,680)

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

回顧24 展望25

大國博弈

貨幣攻略

說說心理話

聖誕新年特輯

Watche Trends 2024

北上食買玩

Artcation

秋冬養生食療

消委會報告

山今養生智慧

輕鬆護老